1. Home
  2. SCOR vs IRD Comparison

SCOR vs IRD Comparison

Compare SCOR & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCOR
  • IRD
  • Stock Information
  • Founded
  • SCOR 1999
  • IRD 2018
  • Country
  • SCOR United States
  • IRD United States
  • Employees
  • SCOR N/A
  • IRD N/A
  • Industry
  • SCOR Business Services
  • IRD
  • Sector
  • SCOR Consumer Discretionary
  • IRD
  • Exchange
  • SCOR Nasdaq
  • IRD NYSE
  • Market Cap
  • SCOR 34.7M
  • IRD 36.1M
  • IPO Year
  • SCOR 2007
  • IRD N/A
  • Fundamental
  • Price
  • SCOR $8.10
  • IRD $1.15
  • Analyst Decision
  • SCOR Buy
  • IRD Strong Buy
  • Analyst Count
  • SCOR 3
  • IRD 1
  • Target Price
  • SCOR $12.83
  • IRD $8.00
  • AVG Volume (30 Days)
  • SCOR 43.2K
  • IRD 154.1K
  • Earning Date
  • SCOR 03-05-2025
  • IRD 02-19-2025
  • Dividend Yield
  • SCOR N/A
  • IRD N/A
  • EPS Growth
  • SCOR N/A
  • IRD N/A
  • EPS
  • SCOR N/A
  • IRD N/A
  • Revenue
  • SCOR $356,212,000.00
  • IRD $8,381,000.00
  • Revenue This Year
  • SCOR N/A
  • IRD N/A
  • Revenue Next Year
  • SCOR $2.92
  • IRD $29.37
  • P/E Ratio
  • SCOR N/A
  • IRD N/A
  • Revenue Growth
  • SCOR N/A
  • IRD N/A
  • 52 Week Low
  • SCOR $4.89
  • IRD $0.81
  • 52 Week High
  • SCOR $20.42
  • IRD $2.77
  • Technical
  • Relative Strength Index (RSI)
  • SCOR 66.50
  • IRD N/A
  • Support Level
  • SCOR $6.82
  • IRD N/A
  • Resistance Level
  • SCOR $7.49
  • IRD N/A
  • Average True Range (ATR)
  • SCOR 0.59
  • IRD 0.00
  • MACD
  • SCOR 0.18
  • IRD 0.00
  • Stochastic Oscillator
  • SCOR 88.87
  • IRD 0.00

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: